Shedding of microparticles by myofibroblasts as mediator of cellular cross-talk during normal wound healing

Journal of Cellular Physiology

Volumn 225, Issue 3, 2010, Pages 734-740

  Moulin, Véronique J ^a,b   Mayrand, Dominique ^a   Messier, Hugo ^a   Martinez, Maria Carmen ^c   Lopez Vallé, Carlos A ^d   Genest, Hervé ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITÉ D'ANGERS   (France)

^d Department of Pediatrics and Clinical Research Unit   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; VASCULOTROPIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ARTICLE; BODY FLUID; CELL COMMUNICATION; CELL GROWTH; CELL INTERACTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MESENCHYME; MOLECULAR WEIGHT; MYOFIBROBLAST; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; WOUND HEALING; ADULT; APOPTOSIS; BLOOD; CELL CULTURE; CELL PROLIFERATION; FIBROBLAST; GRANULATION TISSUE; HYPERTROPHIC SCAR; MEMBRANE MICROPARTICLE; METABOLISM; PATHOLOGY; PHENOTYPE; PROTEIN DENATURATION; SKIN;

ADULT; APOPTOSIS; CELL COMMUNICATION; CELL PROLIFERATION; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; CICATRIX, HYPERTROPHIC; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; GRANULATION TISSUE; HUMANS; MOLECULAR WEIGHT; PHENOTYPE; PROTEIN DENATURATION; SKIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING; YOUNG ADULT;

EID: 77957824532     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22268     Document Type: Article

References (33)

1. Agouni A, Lagrue-Lak-Hal AH, Ducluzeau PH, Mostefai HA, Draunet-Busson C, Leftheriotis G, Heymes C, Martinez MC, Andriantsitohaina R. 2008. Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol 173: 1210-1219.
2. Anderson NL, Anderson NG. 2002. The human plasma proteome: History, character, and diagnostic prospects. Mol Cell Proteomics 1: 845-867.
3. Boulanger CM, Amabile N, Tedgui A. 2006. Circulating microparticles: A potential prognostic marker for atherosclerotic vascular disease. Hypertension 48: 180-186.
4. Bowen-Pope DF, Malpass TW, Foster DM, Ross R. 1984. Platelet-derived growth factor in vivo: Levels, activity, and rate of clearance. Blood 64: 458-469.
5. Chen HH, Zhao S, Song JG. 2003. TGF-beta1 suppresses apoptosis via differential regulation of MAP kinases and ceramide production. Cell Death Differ 10: 516-527.
6. Distler JH, Huber LC, Gay S, Distler O, Pisetsky DS. 2006. Microparticles as mediators of cellular cross-talk in inflammatory disease. Autoimmunity 39: 683-690.
7. Freyssinet JM. 2003. Cellular microparticles: What are they bad or good for? J Thromb Haemost 1: 1655-1662.
8. Gabbiani G. 2003. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 200: 500-503.
9. Germain L, Jean A, Auger F, Garrel DR. 1994. Human wound healing fibroblasts have greater contractile properties than dermal fibroblasts. J Surg Res 57: 268-273.
10. Gospodarowicz D. 1991. Biological activities of fibroblast growth factors. Ann NY Acad Sci 638: 1-8.
11. Graves LE, Ariztia EV, Navari JR, Matzel HJ, Stack MS, Fishman DA. 2004. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res 64: 7045-7049.
12. Hughes CC. 2008. Endothelial-stromal interactions in angiogenesis. Curr Opinion hematol 15: 204-209.
13. Jiang JX, Mikami K, Venugopal S, Li Y, Torok NJ. 2009. Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways. J Hepatol 51: 139-148.
14. Jimenez JJ, Jy W, Mauro LM, Soderland C, Horstman LL, Ahn YS. 2003. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 109: 175-180.
15. Larochelle S, Langlois C, Thibault I, Lopez-Valle CA, Roy M, Moulin V. 2004. Sensitivity of myofibroblasts to H2O2-mediated apoptosis and their antioxidant cell network. J Cell Physiol 200: 263-271.
16. Larsson A, Skoldenberg E, Ericson H. 2002. Serum and plasma levels of FGF-2 and VEGF in healthy blood donors. Angiogenesis 5: 107-110.
17. Lima LG, Chammas R, Monteiro RQ, Moreira ME, Barcinski MA. 2009. Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner. Cancer Lett 283: 168-175.
18. Llorente-Cortes V, Otero-Vinas M, Camino-Lopez S, Llampayas O, Badimon L. 2004. Aggregated low-density lipoprotein uptake induces membrane tissue factor procoagulant activity and microparticle release in human vascular smooth muscle cells. Circulation 110: 452-459.
19. Martinez MC, Tesse A, Zobairi F, Andriantsitohaina R. 2005. Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am J Physiol 288: H1004-H1009.
20. Millimaggi D, Mari M, D'Ascenzo S, Carosa E, Jannini EA, Zucker S, Carta G, Pavan A, Dolo V. 2007. Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells. Neoplasia (New York, NY) 9: 349-357.
21. Moulin V. 1995. Growth factors in skin wound healing. Eur J Cell Biol 68: 1-7.
22. Moulin V, Garrel D, Auger FA, O'Connor-McCourt M, Castilloux G, Germain L. 1999. What's new in human wound healing myofibroblasts? Curr Topics Pathol 93: 123-133.
23. Moulin V, Tam BYY, Castilloux G, Auger FA, O'Connor-McCourt MD, Philip A, Germain L. 2001. Fetal and adult human skin fibroblasts display intrinsic differences in contractile capacity. J Cell Physiol 188: 211-222.
24. Moulin V, Larochelle S, Langlois C, Thibault I, Lopez-Valle CA, Roy M. 2004. Normal skin wound and hypertrophic scar myofibroblasts have differential responses to apoptotic inductors. J Cell Physiol 198: 350-358.
25. Niessen FB, Spauwen PHM, Schalkwijk J, Kon M. 1999. On the nature of hypertrophic scars and keloids: A review. Plast Reconstr Surg 104: 1435-1458.
26. Rizzo S, Killick SB, Patel S, Ball SE, Wadhwa M, Dilger P, Gordon-Smith EC, Gibson FM. 1999. Reduced TGF-beta1 in patients with aplastic anaemia in vivo and in vitro. Br J Haematol 107: 797-803.
27. Rochon M, Auger F, Gauthier MJ, Germain L. 2001. Simultaneous isolation of keratinocytes and fibroblasts from a human cutaneous biopsy for the production of autologous reconstructed skin. Can J Chem Engin 79: 663-667.
28. Rompré P, Auger RA, Germain L, Bouvard V, Lopez Vallé CA, Thibault J, Le Duy A. 1990. Influence of initial collagen and cellular concentrations on the final surface area of dermal and skin equivalents: A Box-Behnken analysis. In Vitro Cell Dev Biol An 26: 983-990.
29. Scherrer B. 1984. Biostatistique. Montreal, Paris: Morin.
30. Shukla A, Dubey MP, Srivastava R, Srivastava BS. 1998. Differential expression of proteins during healing of cutaneous wounds in experimental normal and chronic models. Biochem Biophys Res Comm 244: 434-439.
31. Taraboletti G, D'Ascenzo S, Borsotti P, Giavazzi R, Pavan A, Dolo V. 2002. Shedding of the matrix metalloproteinases MMP-2, MMP-9 and MT-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol 160: 673-680.
32. Taverna S, Ghersi G, Ginestra A, Rigogliuso S, Pecorella S, Alaimo G, Saladino F, Dolo V, Dell'Era P, Pavan A, Pizzolanti G, Mignatti P, Presta M, Vittorelli ML. 2003. Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. J Biol Chem 278: 51911-51919.
33. Zwaal RF, Schroit AJ. 1997. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89: 1121-1132.